Harnett Joanna, Myers Stephen P, Rolfe Margaret
Faculty of Pharmacy, The University of Sydney, Camperdown, Australia.
Division of Research, Southern Cross University, Sydney, Australia.
Gut Pathog. 2017 May 5;9:26. doi: 10.1186/s13099-017-0173-1. eCollection 2017.
Coeliac disease is an autoimmune disorder resulting from an interaction between diet, genome and immunity. The treatment of CoeD is lifelong adherence to a gluten free diet, which is associated with clinical and histological improvements. However, a substantive number of individuals report only partial symptom improvement despite both compliance with a strict gluten free diet and improvements in serological and histological biomarkers of disease activity. The role of the intestinal microbiota is an area of interest in this sub-group.
To investigate the role of yeasts and parasites in individuals reporting persistent symptoms of Coeliac disease (CoeD).
Forty-five people who met the ESPGHAN diagnostic criteria for CoeD were recruited via the Australian Coeliac Association. The faecal measures of the DNA of yeasts and parasites from the CoeD group were compared to data obtained from the medical records of non-coeliac controls with gastrointestinal symptoms from other causes.
sp. was detected in 33% of the CoeD group compared 0% of the control group (p = 0.000) and sp. was detected in 33% of the CoeD group compared to 10% of the control group (p = 0.026). There were no differences in the presence of any of the parasite species measured.
Further research is required to understand the significance of C and species in both the aetiology of CoeD and of persistent symptoms in this sub-group. Clinical Trial Registration-ANZCTR Number: 12610000630011.
乳糜泻是一种由饮食、基因组和免疫相互作用引起的自身免疫性疾病。乳糜泻的治疗是终身坚持无麸质饮食,这与临床和组织学改善相关。然而,相当数量的个体尽管严格遵守无麸质饮食且疾病活动的血清学和组织学生物标志物有所改善,但仍报告症状仅部分改善。肠道微生物群的作用是该亚组中一个受关注的领域。
研究酵母和寄生虫在报告有持续性乳糜泻(CoeD)症状的个体中的作用。
通过澳大利亚乳糜泻协会招募了45名符合ESPGHAN乳糜泻诊断标准的人。将CoeD组酵母和寄生虫DNA的粪便检测结果与从患有其他原因胃肠道症状的非乳糜泻对照的病历中获得的数据进行比较。
CoeD组中33%检测到 菌,而对照组为0%(p = 0.000);CoeD组中33%检测到 菌,而对照组为10%(p = 0.026)。所检测的任何寄生虫种类的存在情况均无差异。
需要进一步研究以了解 菌和 菌在CoeD病因以及该亚组持续性症状中的意义。临床试验注册号 - ANZCTR编号:12610000630011。